Top compounds associated with response to STYK1


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.22 0.005
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.12 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.12 0.005
mRNA Irinotecan gCSI pan-cancer AAC -0.2 0.006
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.12 0.006
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.006
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.12 0.006
Download CSV